Multi-drug resistant gonorrhoea in England: 2018
Microbiological and epidemiological information relating to multi-drug resistant gonorrhoea (MDRGC) in England, the first case being reported in March 2018.
Documents
Details
This is the first global report of N. gonorrhoeae with high-level resistance to azithromycin and resistance to ceftriaxone.
Public Health England (PHE) reminded clinical laboratories to refer N. gonorrhoeae isolates with resistance to ceftriaxone (MIC >0.125 mg/L) or azithromycin (MIC >0.5 mg/L) to the PHE Reference Bacteriology at Colindale for confirmation; General Practitioners were reminded to refer all suspected cases of gonorrhoea to genitourinary medicine services for appropriate management according to PHE guidance.
Updates to this page
Published 27 March 2018Last updated 20 April 2018 + show all updates
-
Added HPR 12(14) first update report.
-
First published.